{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:58:02Z","timestamp":1778309882725,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenzhen Science and Technology Innovation Committee","award":["JCYJ20170818141120342"],"award-info":[{"award-number":["JCYJ20170818141120342"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773939"],"award-info":[{"award-number":["81773939"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771567"],"award-info":[{"award-number":["31771567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31801213"],"award-info":[{"award-number":["31801213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tongue squamous cell carcinoma (TSCC) is a common type of oral cancer, with a relatively poor prognosis and low post-treatment survival rate. Various strategies and novel drugs to treat TSCC are emerging and under investigation. Trichosanthin (TCS), extracted from the root tubers of Tian-Hua-Fen, has been found to have multiple biological and pharmacological functions, including inhibiting the growth of cancer cells. Granzyme B (GrzB) is a common toxic protein secreted by natural killer cells and cytotoxic T cells. Our group has reported that TCS combined with GrzB might be a superior approach to inhibit liver tumor progression, but data relating to the use of this combination to treat TSCC remain limited. The aim of this study was to examine the effectiveness of TCS on TSCC processes and underlying mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>First, we screened the potential antitumor activity of TCS using two types of SCC cell lines. Subsequently, a subcutaneous squamous cell carcinoma xenograft model in nude mice was established. These model mice were randomly divided into four groups and treated as follows: control group, TCS treatment group, GrzB treatment group, and TCS\/GrzB combination treatment group. Various tumorigenesis parameters, such as Ki67, PCNA, caspase-3, Bcl-2 and VEGFA, et al., were performed to determine the effects of these treatments on tumor development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Screening confirmed that the SCC25 line exhibited greater sensitivity than the SCC15 line to TCS in vitro studies. TCS or GrzB treatment significantly inhibited tumor growth compared with the inhibition seen in the control group. The TCS\/GrzB combination inhibited tumor growth more than either drug alone. TCS treatment inhibited tumor proliferation by downregulating Ki67 and Bcl2 protein expression while accelerating tumor apoptosis. In the TCS\/GrzB-treated group, expression of Ki67 was further downregulated, while the level of activated caspase-3 was increased, compared with their expression in either of the single drug treatment groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results suggest that the TCS\/GrzB combination could represent an effective immunotherapy for TSCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-021-03266-6","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T14:03:05Z","timestamp":1615298585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Trichosanthin cooperates with Granzyme B to restrain tumor formation in tongue squamous cell carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Zeyao","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenguang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunliu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunman","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weipeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ou","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"issue":"12","key":"3266_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer. 2010;127(12):2893\u2013917. https:\/\/doi.org\/10.1002\/ijc.25516.","journal-title":"Int J Cancer"},{"issue":"1","key":"3266_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12105-007-0007-4","volume":"1","author":"BW Neville","year":"2007","unstructured":"Neville BW. Update on current trends in oral and maxillofacial pathology. Head Neck Pathol. 2007;1(1):75\u201380. https:\/\/doi.org\/10.1007\/s12105-007-0007-4.","journal-title":"Head Neck Pathol"},{"issue":"6","key":"3266_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/jop.12381","volume":"45","author":"HC Chen","year":"2016","unstructured":"Chen HC, Yang CM, Cheng JT, Tsai KW, Fu TY, Liou HH, Tseng HH, Lee JH, Li GC, Wang JS, Hou YY, Weng TJ, Ger LP. Global DNA hypomethylation is associated with the development and poor prognosis of tongue squamous cell carcinoma. J Oral Pathol Med. 2016;45(6):409\u201317. https:\/\/doi.org\/10.1111\/jop.12381.","journal-title":"J Oral Pathol Med"},{"key":"3266_CR4","doi-asserted-by":"publisher","first-page":"5815493","DOI":"10.1155\/2017\/5815493","volume":"2017","author":"A Le Campion","year":"2017","unstructured":"Le Campion A, Ribeiro CMB, Luiz RR, Da Silva Junior FF, Barros HCS, Dos Santos KCB, Ferreira SJ, Goncalves LS, Ferreira SMS. Low survival rates of oral and oropharyngeal squamous cell carcinoma. Int J Dent. 2017;2017:5815493. https:\/\/doi.org\/10.1155\/2017\/5815493.","journal-title":"Int J Dent"},{"issue":"3\u20134","key":"3266_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-007-9082-y","volume":"26","author":"D Sano","year":"2007","unstructured":"Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev. 2007;26(3\u20134):645\u201362. https:\/\/doi.org\/10.1007\/s10555-007-9082-y.","journal-title":"Cancer Metastasis Rev"},{"key":"3266_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3389\/fonc.2019.00816","volume":"9","author":"Z Yao","year":"2019","unstructured":"Yao Z, Du L, Xu M, Li K, Guo H, Ye G, Zhang D, Coppes RP, Zhang H. Mta3-sox2 module regulates cancer stemness and contributes to clinical outcomes of tongue carcinoma. Front Oncol. 2019;9:816. https:\/\/doi.org\/10.3389\/fonc.2019.00816.","journal-title":"Front Oncol"},{"issue":"1","key":"3266_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cncr.26229","volume":"118","author":"I Ganly","year":"2012","unstructured":"Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer. 2012;118(1):101\u201311. https:\/\/doi.org\/10.1002\/cncr.26229.","journal-title":"Cancer."},{"key":"3266_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1472-6882-14-86","volume":"14","author":"Y Chen","year":"2014","unstructured":"Chen Y, Miao Y, Huang L, Li J, Sun H, Zhao Y, Yang J, Zhou W. Antioxidant activities of saponins extracted from radix trichosanthis: An in vivo and in vitro evaluation. BMC Complement Altern Med. 2014;14:86. https:\/\/doi.org\/10.1186\/1472-6882-14-86.","journal-title":"BMC Complement Altern Med"},{"issue":"6","key":"3266_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00280-013-2096-y","volume":"71","author":"O Sha","year":"2013","unstructured":"Sha O, Niu J, Ng TB, Cho EY, Fu X, Jiang W. Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional chinese medicine: a mini review. Cancer Chemother Pharmacol. 2013;71(6):1387\u201393. https:\/\/doi.org\/10.1007\/s00280-013-2096-y.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"3266_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12640-009-9122-1","volume":"18","author":"O Sha","year":"2010","unstructured":"Sha O, Yew DT, Cho EY, Ng TB, Yuan L, Kwong WH. Mechanism of the specific neuronal toxicity of a type i ribosome-inactivating protein, trichosanthin. Neurotox Res. 2010;18(2):161\u201372. https:\/\/doi.org\/10.1007\/s12640-009-9122-1.","journal-title":"Neurotox Res"},{"issue":"1","key":"3266_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/mmr.2015.4531","volume":"13","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Sun Y, Cai Y, Sha O, Jiang W. Trichosanthin reduces the viability of sudhl2 cells via the activation of the extrinsic and intrinsic apoptotic pathways. Mol Med Rep. 2016;13(1):403\u201311. https:\/\/doi.org\/10.3892\/mmr.2015.4531.","journal-title":"Mol Med Rep"},{"issue":"6","key":"3266_CR12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/ar.21142","volume":"293","author":"M Li","year":"2010","unstructured":"Li M, Li X, Li JC. Possible mechanisms of trichosanthin-induced apoptosis of tumor cells. Anat Rec (Hoboken). 2010;293(6):986\u201392. https:\/\/doi.org\/10.1002\/ar.21142.","journal-title":"Anat Rec (Hoboken)"},{"issue":"4","key":"3266_CR13","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.prp.2018.12.010","volume":"215","author":"Y Chen","year":"2019","unstructured":"Chen Y, Han L, Bai L, Tang H, Zheng A. Trichosanthin inhibits the proliferation of cervical cancer cells and downregulates stat-5\/c-myc signaling pathway. Pathol Res Pract. 2019;215(4):632\u20138. https:\/\/doi.org\/10.1016\/j.prp.2018.12.010.","journal-title":"Pathol Res Pract"},{"issue":"32","key":"3266_CR14","doi-asserted-by":"publisher","first-page":"26648","DOI":"10.1021\/acsami.7b05292","volume":"9","author":"Y Tang","year":"2017","unstructured":"Tang Y, Liang J, Wu A, Chen Y, Zhao P, Lin T, Zhang M, Xu Q, Wang J, Huang Y. Co-delivery of trichosanthin and albendazole by nano-self-assembly for overcoming tumor multidrug-resistance and metastasis. ACS Appl Mater Interfaces. 2017;9(32):26648\u201364. https:\/\/doi.org\/10.1021\/acsami.7b05292.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"3266_CR15","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.3892\/etm.2017.5286","volume":"14","author":"N Tuya","year":"2017","unstructured":"Tuya N, Wang Y, Tong L, Gao W, Yu R, Xue L. Trichosanthin enhances the antitumor effect of gemcitabine in non-small cell lung cancer via inhibition of the pi3k\/akt pathway. Exp Ther Med. 2017;14(6):5767\u201372. https:\/\/doi.org\/10.3892\/etm.2017.5286.","journal-title":"Exp Ther Med"},{"issue":"2","key":"3266_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.7150\/ijbs.22811","volume":"14","author":"C You","year":"2018","unstructured":"You C, Sun Y, Zhang S, Tang G, Zhang N, Li C, Tian X, Ma S, Luo Y, Sun W, Wang F, Liu X, Xiao Y, Gong Y, Zhang J, Xie C. Trichosanthin enhances sensitivity of non-small cell lung cancer (nsclc) trail-resistance cells. Int J Biol Sci. 2018;14(2):217\u201327. https:\/\/doi.org\/10.7150\/ijbs.22811.","journal-title":"Int J Biol Sci"},{"issue":"16","key":"3266_CR17","doi-asserted-by":"publisher","first-page":"26460","DOI":"10.18632\/oncotarget.15518","volume":"8","author":"C Li","year":"2017","unstructured":"Li C, Zeng M, Chi H, Shen J, Ng TB, Jin G, Lu D, Fan X, Xiong B, Xiao Z, Sha O. Trichosanthin increases granzyme b penetration into tumor cells by upregulation of ci-mpr on the cell surface. Oncotarget. 2017;8(16):26460\u201370. https:\/\/doi.org\/10.18632\/oncotarget.15518.","journal-title":"Oncotarget"},{"issue":"9","key":"3266_CR18","doi-asserted-by":"publisher","first-page":"e41592","DOI":"10.1371\/journal.pone.0041592","volume":"7","author":"EF Fang","year":"2012","unstructured":"Fang EF, Zhang CZ, Zhang L, Wong JH, Chan YS, Pan WL, Dan XL, Yin CM, Cho CH, Ng TB. Trichosanthin inhibits breast cancer cell proliferation in both cell lines and nude mice by promotion of apoptosis. PLoS One. 2012;7(9):e41592. https:\/\/doi.org\/10.1371\/journal.pone.0041592.","journal-title":"PLoS One"},{"issue":"1","key":"3266_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.176.1.97","volume":"176","author":"V Sharma","year":"2006","unstructured":"Sharma V, Delgado M, Ganea D. Granzyme b, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in th2 but not th1 effectors. J Immunol. 2006;176(1):97\u2013110. https:\/\/doi.org\/10.4049\/jimmunol.176.1.97.","journal-title":"J Immunol"},{"issue":"3","key":"3266_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1083\/jcb.200406115","volume":"167","author":"J Pardo","year":"2004","unstructured":"Pardo J, Bosque A, Brehm R, Wallich R, Naval J, Mullbacher A, Anel A, Simon MM. Apoptotic pathways are selectively activated by granzyme a and\/or granzyme b in ctl-mediated target cell lysis. J Cell Biol. 2004;167(3):457\u201368. https:\/\/doi.org\/10.1083\/jcb.200406115.","journal-title":"J Cell Biol"},{"issue":"3","key":"3266_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.88","volume":"8","author":"L Yin","year":"2017","unstructured":"Yin L, Jiang LP, Shen QS, Xiong QX, Zhuo X, Zhang LL, Yu HJ, Guo X, Luo Y, Dong J, Kong QP, Yang CP, Chen YB. Ncaph plays important roles in human colon cancer. Cell Death Dis. 2017;8(3):e2680. https:\/\/doi.org\/10.1038\/cddis.2017.88.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3266_CR22","doi-asserted-by":"publisher","first-page":"e83869","DOI":"10.1371\/journal.pone.0083869","volume":"8","author":"T Wu","year":"2013","unstructured":"Wu T, Jia J, Xiong X, He H, Bu L, Zhao Z, Huang C, Zhang W. Increased expression of lin28b associates with poor prognosis in patients with oral squamous cell carcinoma. PLoS One. 2013;8(12):e83869. https:\/\/doi.org\/10.1371\/journal.pone.0083869.","journal-title":"PLoS One"},{"issue":"1","key":"3266_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1747-4477.2003.tb00494.x","volume":"29","author":"TR Tripi","year":"2003","unstructured":"Tripi TR, Bonaccorso A, Rapisarda E, Bartoloni G. Proliferative activity in periapical lesions. Aust Endod J. 2003;29(1):31\u20133. https:\/\/doi.org\/10.1111\/j.1747-4477.2003.tb00494.x.","journal-title":"Aust Endod J"},{"issue":"1","key":"3266_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.cdd.4402028","volume":"14","author":"Q Bao","year":"2007","unstructured":"Bao Q, Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 2007;14(1):56\u201365. https:\/\/doi.org\/10.1038\/sj.cdd.4402028.","journal-title":"Cell Death Differ"},{"issue":"18","key":"3266_CR25","doi-asserted-by":"publisher","first-page":"10410","DOI":"10.1073\/pnas.181344498","volume":"98","author":"J Munger","year":"2001","unstructured":"Munger J, Roizman B. The us3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of bad and prevents bad-induced programmed cell death in the absence of other viral proteins. Proc Natl Acad Sci U S A. 2001;98(18):10410\u20135. https:\/\/doi.org\/10.1073\/pnas.181344498.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"3266_CR26","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/febs.12831","volume":"281","author":"K Nakazawa","year":"2014","unstructured":"Nakazawa K, Dashzeveg N, Yoshida K. Tumor suppressor p53 induces mir-1915 processing to inhibit bcl-2 in the apoptotic response to DNA damage. FEBS J. 2014;281(13):2937\u201344. https:\/\/doi.org\/10.1111\/febs.12831.","journal-title":"FEBS J"},{"issue":"8","key":"3266_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc2403","volume":"8","author":"LM Ellis","year":"2008","unstructured":"Ellis LM, Hicklin DJ. Vegf-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 2008;8(8):579\u201391. https:\/\/doi.org\/10.1038\/nrc2403.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3266_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1634\/theoncologist.10-6-382","volume":"10","author":"LS Rosen","year":"2005","unstructured":"Rosen LS. Vegf-targeted therapy: therapeutic potential and recent advances. Oncologist. 2005;10(6):382\u201391. https:\/\/doi.org\/10.1634\/theoncologist.10-6-382.","journal-title":"Oncologist."},{"issue":"3","key":"3266_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s1368-8375(02)00049-0","volume":"39","author":"EM Genden","year":"2003","unstructured":"Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C. Neck disease and distant metastases. Oral Oncol. 2003;39(3):207\u201312. https:\/\/doi.org\/10.1016\/s1368-8375(02)00049-0.","journal-title":"Oral Oncol"},{"issue":"3","key":"3266_CR30","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1096\/fj.14-260083","volume":"29","author":"P Dillenburg-Pilla","year":"2015","unstructured":"Dillenburg-Pilla P, Patel V, Mikelis CM, Zarate-Blades CR, Doci CL, Amornphimoltham P, Wang Z, Martin D, Leelahavanichkul K, Dorsam RT, Masedunskas A, Weigert R, Molinolo AA, Gutkind JS. Sdf-1\/cxcl12 induces directional cell migration and spontaneous metastasis via a cxcr4\/galphai\/mtorc1 axis. FASEB J. 2015;29(3):1056\u201368. https:\/\/doi.org\/10.1096\/fj.14-260083.","journal-title":"FASEB J"},{"issue":"6","key":"3266_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/COC.0b013e31827e5505","volume":"37","author":"BJ Gebhardt","year":"2014","unstructured":"Gebhardt BJ, Mendenhall CM, Morris CG, Kirwan J, Mcafee WJ, Mendenhall WM. Radiotherapy alone or combined with chemotherapy for the treatment of squamous cell carcinoma of the base of the tongue. Am J Clin Oncol. 2014;37(6):535\u20138. https:\/\/doi.org\/10.1097\/COC.0b013e31827e5505.","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"3266_CR32","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1007\/s00784-018-2689-2","volume":"23","author":"S Kina","year":"2019","unstructured":"Kina S, Nakasone T, Kinjo T, Nimura F, Sunagawa N, Arasaki A. Outcomes after up-front surgery and metronomic neoadjuvant chemotherapy with s-1 or uft for early tongue squamous cell carcinoma. Clin Oral Investig. 2019;23(6):2593\u20138. https:\/\/doi.org\/10.1007\/s00784-018-2689-2.","journal-title":"Clin Oral Investig"},{"issue":"10","key":"3266_CR33","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/archotol.131.10.874","volume":"131","author":"BA Schiff","year":"2005","unstructured":"Schiff BA, Roberts DB, El-Naggar A, Garden AS, Myers JN. Selective vs modified radical neck dissection and postoperative radiotherapy vs observation in the treatment of squamous cell carcinoma of the oral tongue. Arch Otolaryngol Head Neck Surg. 2005;131(10):874\u20138. https:\/\/doi.org\/10.1001\/archotol.131.10.874.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"3","key":"3266_CR34","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2273.2004.00812.x","volume":"29","author":"SC Winter","year":"2004","unstructured":"Winter SC, Cassell O, Corbridge RJ, Goodacre T, Cox GJ. Quality of life following resection, free flap reconstruction and postoperative external beam radiotherapy for squamous cell carcinoma of the base of tongue. Clin Otolaryngol Allied Sci. 2004;29(3):274\u20138. https:\/\/doi.org\/10.1111\/j.1365-2273.2004.00812.x.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"7","key":"3266_CR35","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/00016489.2017.1279751","volume":"137","author":"A Kamali","year":"2017","unstructured":"Kamali A, Gahm C, Palmgren B, Marklund L, Halle M, Hammarstedt-Nordenvall L. Regional recurrence in early stage i-ii oral tongue cancer: a single institutional study and review of the literature. Acta Otolaryngol. 2017;137(7):755\u201361. https:\/\/doi.org\/10.1080\/00016489.2017.1279751.","journal-title":"Acta Otolaryngol"},{"key":"3266_CR36","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.biopha.2017.11.024","volume":"97","author":"JK Liao","year":"2018","unstructured":"Liao JK, Zhou B, Zhuang XM, Zhuang PL, Zhang DM, Chen WL. Cancer-associated fi broblasts confer cisplatin resistance of tongue cancer via autophagy activation. Biomed Pharmacother. 2018;97:1341\u20138. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.024.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"3266_CR37","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.oraloncology.2008.10.007","volume":"45","author":"YW Chen","year":"2009","unstructured":"Chen YW, Lin GJ, Chia WT, Lin CK, Chuang YP, Sytwu HK. Triptolide exerts anti-tumor effect on oral cancer and kb cells in vitro and in vivo. Oral Oncol. 2009;45(7):562\u20138. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.10.007.","journal-title":"Oral Oncol"},{"issue":"5","key":"3266_CR38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.oraloncology.2013.12.023","volume":"50","author":"CB Gonzales","year":"2014","unstructured":"Gonzales CB, Kirma NB, De La Chapa JJ, Chen R, Henry MA, Luo S, Hargreaves KM. Vanilloids induce oral cancer apoptosis independent of trpv1. Oral Oncol. 2014;50(5):437\u201347. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.12.023.","journal-title":"Oral Oncol"},{"issue":"2\u20133","key":"3266_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/s0014-5793(00)01389-2","volume":"471","author":"TK Au","year":"2000","unstructured":"Au TK, Collins RA, Lam TL, Ng TB, Fong WP, Wan DC. The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of hiv-1 integrase. FEBS Lett. 2000;471(2\u20133):169\u201372. https:\/\/doi.org\/10.1016\/s0014-5793(00)01389-2.","journal-title":"FEBS Lett"},{"issue":"8","key":"3266_CR40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s40880-015-0030-x","volume":"34","author":"M Zeng","year":"2015","unstructured":"Zeng M, Zheng M, Lu D, Wang J, Jiang W, Sha O. Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins. Chin J Cancer. 2015;34(8):325\u201334. https:\/\/doi.org\/10.1186\/s40880-015-0030-x.","journal-title":"Chin J Cancer"},{"issue":"1","key":"3266_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bbagen.2006.07.011","volume":"1770","author":"J Li","year":"2007","unstructured":"Li J, Xia X, Nie H, Smith MA, Zhu X. Pkc inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line k562. Biochim Biophys Acta. 2007;1770(1):63\u201370. https:\/\/doi.org\/10.1016\/j.bbagen.2006.07.011.","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 3","key":"3266_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1042\/bj3550653","volume":"355","author":"C Zhang","year":"2001","unstructured":"Zhang C, Gong Y, Ma H, An C, Chen D, Chen ZL. Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells. Biochem J. 2001;355(Pt 3):653\u201361. https:\/\/doi.org\/10.1042\/bj3550653.","journal-title":"Biochem J"},{"issue":"3","key":"3266_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/s0006-291x(02)02076-4","volume":"297","author":"X Cai","year":"2002","unstructured":"Cai X, Yao G, Xu G, Yang C, Xu H, Lin Y, Yu J, Sun B. Identification of the amino acid residues in trichosanthin crucial for ige response. Biochem Biophys Res Commun. 2002;297(3):510\u20136. https:\/\/doi.org\/10.1016\/s0006-291x(02)02076-4.","journal-title":"Biochem Biophys Res Commun"},{"key":"3266_CR44","doi-asserted-by":"publisher","first-page":"e725","DOI":"10.1038\/cddis.2013.250","volume":"4","author":"K Boland","year":"2013","unstructured":"Boland K, Flanagan L, Prehn JH. Paracrine control of tissue regeneration and cell proliferation by caspase-3. Cell Death Dis. 2013;4:e725. https:\/\/doi.org\/10.1038\/cddis.2013.250.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3266_CR45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0163-7258(01)00159-0","volume":"92","author":"KC Zimmermann","year":"2001","unstructured":"Zimmermann KC, Bonzon C, Green DR. The machinery of programmed cell death. Pharmacol Ther. 2001;92(1):57\u201370. https:\/\/doi.org\/10.1016\/s0163-7258(01)00159-0.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3266_CR46","doi-asserted-by":"publisher","first-page":"16635","DOI":"10.1038\/s41598-017-16653-2","volume":"7","author":"MK Shim","year":"2017","unstructured":"Shim MK, Yoon HY, Lee S, Jo MK, Park J, Kim JH, Jeong SY, Kwon IC, Kim K. Caspase-3\/\u22127-specific metabolic precursor for bioorthogonal tracking of tumor apoptosis. Sci Rep. 2017;7(1):16635. https:\/\/doi.org\/10.1038\/s41598-017-16653-2.","journal-title":"Sci Rep"},{"issue":"11","key":"3266_CR47","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/81343","volume":"6","author":"TS Zheng","year":"2000","unstructured":"Zheng TS, Hunot S, Kuida K, Momoi T, Srinivasan A, Nicholson DW, Lazebnik Y, Flavell RA. Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation. Nat Med. 2000;6(11):1241\u20137. https:\/\/doi.org\/10.1038\/81343.","journal-title":"Nat Med"},{"issue":"5762","key":"3266_CR48","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1126\/science.1115035","volume":"311","author":"SA Lakhani","year":"2006","unstructured":"Lakhani SA, Masud A, Kuida K, Porter GA Jr, Booth CJ, Mehal WZ, Inayat I, Flavell RA. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science. 2006;311(5762):847\u201351. https:\/\/doi.org\/10.1126\/science.1115035.","journal-title":"Science"},{"issue":"5","key":"3266_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell."},{"issue":"12","key":"3266_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11912-020-00981-0","volume":"22","author":"M Peravali","year":"2020","unstructured":"Peravali M, Wang H, Kim C, Veytsman I. Combined inhibition of egfr and vegf pathways in patients with egfr-mutated non-small cell lung cancer: a systematic review and meta-analysis. Curr Oncol Rep. 2020;22(12):119. https:\/\/doi.org\/10.1007\/s11912-020-00981-0.","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"3266_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2012.11.080","volume":"430","author":"D He","year":"2013","unstructured":"He D, Jin J, Zheng Y, Bruce IC, Tam S, Ma X. Anti-angiogenesis effect of trichosanthin and the underlying mechanism. Biochem Biophys Res Commun. 2013;430(2):735\u201340. https:\/\/doi.org\/10.1016\/j.bbrc.2012.11.080.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03266-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-021-03266-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-021-03266-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T14:05:56Z","timestamp":1615298756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-021-03266-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3266"],"URL":"https:\/\/doi.org\/10.1186\/s12906-021-03266-6","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Peking University Shenzhen Graduate School and were performed according to the animal license.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}